CIK 0000886744 · Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752287752
- Phone
- 6504737700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-11 | LAWLIS V BRYAN Director | Option exercise · Stock Options (right to buy) 10b5-1 | −35,000 | 0 | ||
| 2023-05-01 | Molineaux Susan Director | Option exercise | +35,000 | $1.10 | $39K | 35,000 |
| 2023-05-01 | Molineaux Susan Director | Sale | −35,000 | $2.48 | $87K | 0 |
| 2023-05-01 | Molineaux Susan Director | Option exercise · Stock Options (right to buy) | −35,000 | 0 | ||
| 2023-03-31 | Molineaux Susan Director | Grant or award | +6,048 | 114,028 | ||
| 2023-03-31 | Spiegel Robert J. Director | Grant or award | +3,312 | 155,005 | ||
| 2023-02-22 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award · Employee Stock Option (right to buy) | +625,000 | 625,000 | ||
| 2023-02-22 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +780,000 | 780,000 | ||
| 2023-02-22 | Feller Faye EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +540,000 | 540,000 | ||
| 2023-02-22 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +575,000 | 575,000 | ||
| 2023-02-22 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (Right to buy) | +1,750,000 | 1,750,000 | ||
| 2023-02-09 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Option exercise | +150,000 | $1.51 | $227K | 384,719 |
| 2023-02-09 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Sale | −150,000 | $3.03 | $455K | 234,719 |
| 2023-02-09 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Sale | −234,719 | $3.03 | $711K | 0 |
| 2023-02-09 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Option exercise · Employee Stock Option (right to buy) | −150,000 | 0 | ||
| 2023-02-08 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Option exercise | +400,000 | $1.51 | $604K | 474,588 |
| 2023-02-08 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Sale | −400,000 | $3.08 | $1.2M | 74,588 |
| 2023-02-08 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −400,000 | 0 |
Page 7 of 7 · 138 trades